Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-12-20Clinical Trial Update: Observation in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Treated on Clinical Trial CAN-NCIC-LY9
Clinical trial update reporting observational data from patients with diffuse large B-cell lymphoma treated on CAN-NCIC-LY9. The current stu…
-
CLINICAL_TRIALS trial_result · 2011-11-29Clinical Trial Update: The Impact of Rituximab in Patients With Primary Breast Diffuse Large B Cell Lymphoma (DLBCL)
A completed clinical trial evaluating the impact of Rituximab in patients with primary breast diffuse large B-cell lymphoma.
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Prognosis Of Patients With Aggressive B-Cell Lymphoma, Treated With Rituximab+Anthracycline Regimen
Update on prognosis for patients with aggressive B-cell lymphoma treated with a rituximab-containing anthracycline regimen, based on complet…
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: Study of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody to Treat Non-hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating a recombinant human-mouse chimeric anti-CD20 monoclonal antibody for diffuse large B-cell lymphoma (a type of non…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the safety and preliminary efficacy of SGN-30 (brentuximab vedotin) in patients with CD30-positive …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant [Phase 2]
A Phase 2 study evaluating ofatumumab in relapsed or progressive diffuse large B-cell lymphoma patients who are transplant-ineligible or rel…
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV
The document reports an update on an early on-therapy PET imaging study conducted during first-line treatment for diffuse large B-cell lymph…
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies [Phase 2]
Phase II study assessing AT-101 as a single-agent therapy in relapsed or refractory B-cell malignancies has completed, reporting safety and …
-
CLINICAL_TRIALS trial_result · 2011-06-28Clinical Trial Update: Biocell Natural Killer Mixture in Diffuse Large B Cell Lymphoma (DLBCL) Patients [Phase 3]
A Phase 3 clinical trial update for Biocell Natural Killer Mixture in diffuse large B-cell lymphoma (DLBCL) is ongoing, sponsored by NKBio C…
-
CLINICAL_TRIALS trial_result · 2011-05-02Clinical Trial Update: Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
A Phase 2 trial of rituximab plus gemcitabine for relapsed or refractory diffuse large B-cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 [Phase 3]
Phase 3 trial comparing ACVBP plus Rituximab vs CHOP plus Rituximab in patients with diffuse large B-cell lymphoma and an age-adjusted IPI o…
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 study evaluating oblimersen sodium in combination with rituximab for recurrent B-cell non-Hodgkin lymphoma completed, with results…
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: TREatment of degeNerative and Neoplastic Diseases With Rituximab [Phase 2, Phase 3]
A clinical trial update on treating diffuse large B-cell lymphoma with rituximab in Phase 2 and Phase 3, sponsored by Probiomed S.A. de C.V.
-
CLINICAL_TRIALS trial_result · 2010-11-18Clinical Trial Update: Yt90 Zevalin and Combination Chemotherapy (Z-CHOP)in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-cell Lymphoma [Phase 2]
Phase 2 study evaluating Yttrium-90 Zevalin with Z-CHOP chemotherapy for stage II-IV Diffuse large B-cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2010-07-08Clinical Trial Update: 90Y-ibritumomab Tiuxetan Consolidation After 6th R-CHOP Chemotherapy in Patients With Bulky Diffuse Large B Cell Lymphoma [Phase 2]
Phase 2 study evaluating consolidation with 90Y-ibritumomab tiuxetan after six cycles of R-CHOP in patients with bulky diffuse large B-cell …
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: 30Gy Versus 40Gy Involved-field Radiotherapy for Localized Diffuse Large B Cell Lymphoma Achieving CR After Chemotherapy [Phase 3]
This Phase 3 trial compares 30 Gy versus 40 Gy involved-field radiotherapy in patients with localized diffuse large B-cell lymphoma who achi…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL [Phase 3]
A Phase 3 trial comparing R-CHOP versus R-mini-CEOP in elderly patients with diffuse large B-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2009-11-25Clinical Trial Update: LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV) [Phase 4]
A Phase 4 study evaluating chemotherapy plus rituximab and highly active antiretroviral therapy for patients with diffuse large B-cell lymph…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma [Phase 2]
This update reports results from a Phase 2 trial of high-dose chemotherapy with rituximab in adults with aggressive diffuse large B-cell lym…
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 study evaluating lenalidomide in combination with dexamethasone for relapsed or refractory diffuse large B-cell lymphoma was termina…
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) [Phase 2]
Phase 2 clinical trial evaluating treosulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation, focusing on saf…
-
CLINICAL_TRIALS trial_result · 2009-05-07Clinical Trial Update: Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease [Phase 2]
A Phase II trial of thalidomide in refractory/relapsed diffuse large B-cell lymphoma and Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-07Clinical Trial Update: Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma [Phase 1]
Phase 1 study evaluating a combination of oblimersen with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients …
-
CLINICAL_TRIALS trial_result · 2009-02-25Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy [Phase 2]
A Phase 2 study assessing the efficacy and safety of Zevalin (ibritumomab tiuxetan) as subsequent therapy in elderly patients with Diffuse L…
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma [Phase 3]
This Phase 3 clinical trial evaluated stem cell transplantation with or without Rituximab in patients with relapsed or progressive Diffuse L…